1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Internal Neurostimulation Market, by Type, by Application, by Geography – Analysis & Forecasts To 2019

Internal neurostimulation involves a surgical implantation of electrodes at specific areas, either in the dura mater or deep inside the brain. Medical practitioners measure the invasiveness of any surgical procedure or therapeutic device, based on incision size, collateral tissue damage, and recovery period. Thus, minimally invasive technologies are surgical techniques that reduce the physical impact of a medical procedure. The use of internal neurostimulation (minimally invasive) devices reduces the length of hospital stay, post-surgical complications, and improves the quality of life. The long-term cost savings associated with the use of minimally invasive neurostimulation devices has contributed to the significant growth of the internal neurostimulation market.

In addition to this, increasing neurostimulation research activities to treat diabetes, widespread awareness associated with the benefits of neurostimulation methods, and growing prevalence of neurological disorders have equally contributed to the overall growth of the global internal neurostimulation market.
The global internal neurostimulation market was valued at $4,850.1 million in 2014, and is expected to reach $8,585.1 million by 2019, at a CAGR of 12.1% from 2014 to 2019. The North American internal neurostimulation market was valued at $2,513.0 million in 2014, and is expected to reach $4,186.1 million by 2019, at a CAGR of 10.7% during the forecast period.


Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging and high-growth segments of the internal neurostimulation market, high-growth regions and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

• Product Analysis and development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the global internal neurostimulation market. Usage pattern/ penetration rate (in-depth trend analysis) of products (Segment wise), and purchasing data. Comprehensive coverage of product approvals and product recalls.
• Market Development: Comprehensive information about emerging markets
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the global internal neurostimulation market. Detailed description regarding the related and unrelated diversification pertaining to this market.
• Competitive Assessment: In-depth assessment of market shares and company share analysis of key players. Develop business strategies and manufacturing capabilities of leading players that enhance the bottom line of companies in the global internal neurostimulation market.
• Product/ Brand Perception Analysis: Comprehensive study of customers perception and behavior through our inbuilt social connect tool (digital marketing language), by checking the virality and tonality of blogs.

Table Of Contents

Internal Neurostimulation Market, by Type, by Application, by Geography - Analysis and Forecasts To 2019
TABLE OF CONTENTS


1 INTRODUCTION 10
1.1 OBJECTIVES OF THE STUDY 10
1.2 MARKET SEGMENTATION and COVERAGE 11
1.3 STAKEHOLDERS 12
2 RESEARCH METHODOLOGY 13
2.1 INTEGRATED ECOSYSTEM OF THE INTERNAL NEUROSTIMULATION MARKET 13
2.2 ARRIVING AT THE INTERNAL NEUROSTIMULATION MARKET SIZE 14
2.2.1 TOP-DOWN APPROACH 14
2.2.2 BOTTOM-UP APPROACH 16
2.2.3 MACROINDICATOR-BASED APPROACH 17
2.3 ASSUMPTIONS 18
3 EXECUTIVE SUMMARY 19
4 MARKET OVERVIEW 21
4.1 INTRODUCTION 21
4.2 INTERNAL NEUROSTIMULATION MARKET: COMPARISON WITH PARENT MARKET 21
4.3 MARKET DRIVERS AND INHIBITORS 23
5 INTERNAL NEUROSTIMULATION MARKET, BY TYPE 25
5.1 INTRODUCTION 26
5.2 GLOBAL: SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY 27
5.3 GLOBAL DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY 28
5.4 GLOBAL SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY 30
5.5 SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN) 31
5.6 GLOBAL VAGUS NERVE STIMULATION MARKET, BY GEOGRAPHY 32
5.7 GLOBAL GASTRIC ELECTRICAL STIMULATION MARKET, BY GEOGRAPHY 33
6 INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION 35
6.1 INTRODUCTION 36
6.2 GLOBAL INTERNAL NEUROSTIMULATION IN PARKINSON'S DISEASE , BY GEOGRAPHY 38
6.3 GLOBAL INTERNAL NEUROSTIMULATION IN TREMOR, BY GEOGRAPHY 39
6.4 GLOBAL INTERNAL NEUROSTIMULATION IN DEPRESSION, BY GEOGRAPHY 40
6.5 GLOBAL INTERNAL NEUROSTIMULATION IN OTHER APPLICATIONS , BY GEOGRAPHY 41
7 INTERNAL NEUROSTIMULATION MARKET, BY GEOGRAPHY 43
7.1 INTRODUCTION 44
7.2 NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET 44
7.2.1 NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION 45
7.2.2 NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET, BY TYPE 46
7.3 EUROPE INTERNAL NEUROSTIMULATION MARKET 48
7.3.1 EUROPE INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION 48
7.3.2 EUROPE INTERNAL NEUROSTIMULATION MARKET, BY TYPE 50
7.4 ASIA: INTERNAL NEUROSTIMULATION MARKET 51
7.4.1 ASIA INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION 52
7.4.2 ASIA INTERNAL NEUROSTIMULATION MARKET, BY TYPE 53
7.5 ROW INTERNAL NEUROSTIMULATION MARKET 55
7.5.1 ROW INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION 56
7.5.2 ROW INTERNAL NEUROSTIMULATION MARKET, BY TYPE 57
8 INTERNAL NEUROSTIMULATION MARKET: COMPETITIVE LANDSCAPE 59
8.1 INTERNAL NEUROSTIMULATION MARKET: BY COMPANY 59
8.2 COMPANY PRESENCE IN INTERNAL NEUROSTIMULATION MARKET, BY TYPE 60
8.3 NEW PRODUCT LAUNCH 60
8.4 REGULATORY APPROVALS 61
8.5 AGREEMENTS 62
9 INTERNAL NEUROSTIMULATION MARKET, BY COMPANY 63
(Overview, Financials, Products and Services, Strategy, and Developments)*
9.1 BOSTON SCIENTIFIC CORPORATION (U.S.) 63
9.2 CYBERONICS, INC. (U.S.) 66
9.3 DEPUY SYNTHES COMPANIES (U.S.) 68
9.4 ENTEROMEDICS, INC. (U.S.) 71
9.5 MEDTRONIC, PLC. (U.S.) 73
9.6 ST. JUDE MEDICAL (U.S.) 76
9.7 SYNAPSE BIOMEDICAL, INC. (U.S.) 80
9.8 UROPLASTY, INC. (U.S.) 82
*Details on overview, financials, product and services, strategy, and developments might not be captured in case of unlisted company
10 APPENDIX 84
10.1 CUSTOMIZATION OPTIONS 84
10.1.1 PRODUCT ANALYSIS 84
10.1.2 EPIDEMIOLOGY DATA 84
10.1.3 SURGEONS/PHYSICIANS PERCEPTION ANALYSIS 84
10.1.4 REGULATORY FRAMEWORK 84
10.2 RELATED REPORTS 85
10.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 86
10.3.1 SNAPSHOTS 87

LIST OF TABLES



TABLE 1 GLOBAL INTERNAL NEUROSTIMULATION PEER MARKET SIZE, 2014 (USD MN) 15
TABLE 2 GLOBAL INTERNAL NEUROSTIMULATION MARKET: MACROINDICATORS,
BY GEOGRAPHY, 2014 (USD MN) 17
TABLE 3 GLOBAL: INTERNAL NEUROSTIMULATION MARKET: COMPARISON WITH PARENT MARKET, 2013-2019 (USD MN) 22
TABLE 4 INTERNAL NEUROSTIMULATION MARKET, BY GEOGRAPHY, 2014 (USD MN) 22
TABLE 5 GLOBAL: INTERNAL NEUROSTIMULATION MARKET: DRIVERS AND INHIBITORS 23
TABLE 6 GLOBAL INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN) 26
TABLE 7 SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN) 28
TABLE 8 DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN) 29
TABLE 9 VAGUS NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN) 33
TABLE 10 GASTRIC ELECTRICAL STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN) 34
TABLE 11 GLOBAL INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN) 37
TABLE 12 GLOBAL INTERNAL NEUROSTIMULATION IN PARKINSON'S DISEASE, BY GEOGRAPHY, 2013-2019 (USD MN) 38
TABLE 13 GLOBAL INTERNAL NEUROSTIMULATION IN TREMOR, BY GEOGRAPHY,
2013-2019 (USD MN) 39
TABLE 14 GLOBAL INTERNAL NEUROSTIMULATION IN DEPRESSION, BY GEOGRAPHY,
2013-2019(USD MN) 40
TABLE 15 GLOBAL INTERNAL NEUROSTIMULATION IN OTHER APPLICATIONS, BY GEOGRAPHY, 2013-2019(USD MN) 42
TABLE 16 GLOBAL INTERNAL NEUROSTIMULATION MARKET, BY GEOGRAPHY,
2013-2019 (USD MN) 44
TABLE 17 NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION,
2013-2019 (USD MN) 45
TABLE 18 NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET, BY TYPE,
2013-2019 (USD MN) 47
TABLE 19 EUROPE INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION,
2013-2019 (USD MN) 49
TABLE 20 EUROPE: INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN) 50
TABLE 21 ASIA INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN) 52
TABLE 22 ASIA INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019(USD MN) 54
TABLE 23 ROW INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION,
2013-2019 (USD MN) 56
TABLE 24 ROW INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN) 58
TABLE 25 INTERNAL NEUROSTIMULATION MARKET, BY COMPANY 59
TABLE 26 INTERNAL NEUROSTIMULATION MARKET: COMPANY SHARE ANALYSIS, 2013(%) 59
TABLE 27 GLOBAL INTERNAL NEUROSTIMULATION MARKET: NEW PRODUCT LAUNCH 60
TABLE 28 GLOBAL INTERNAL NEUROSTIMULATION MARKET: REGULATORY APPROVALS 61
TABLE 29 GLOBAL INTERNAL NEUROSTIMULATION MARKET: AGREEMENTS 62
TABLE 30 BOSTON SCIENTIFIC CORPORATION: REVENUE, BY BUSINESS SEGMENT,
2009 - 2013 (USD MN) 64
TABLE 31 BOSTON SCIENTIFIC: REVENUE, BY GEOGRAPHICAL SEGMENTS, 2009 - 2012 (USD MN) 64
TABLE 32 CYBERONICS, INC.: KEY FINANCIALS, 2009 - 2013 (USD MN) 66
TABLE 33 JOHNSON and JOHNSON, INC. : REVENUE, BY BUSINESS SEGMENT,
2009 - 2013 (USD MN) 69
TABLE 34 JOHNSON and JOHNSON, INC.: REVENUE, 2009 - 2013 (USD MN) 69
TABLE 35 MEDTRONIC, INC. : REVENUE, BY BUSINESS SEGMENT, 2009 - 2013 (USD MN) 74
TABLE 36 MEDTRONIC, INC. : REVENUE, BY GEOGRAPHICAL SEGMENT, 2009 - 2013 (USD MN) 74
TABLE 37 ST. JUDE MEDICAL: REVENUE, BY BUSINESS SEGMENT, 2011 - 2013 (USD MN) 77
TABLE 38 ST. JUDE MEDICAL: REVENUE, BY GEOGRAPHICAL SEGMENT, 2008 - 2013 (USD MN) 77
TABLE 39 UROPLASTY, INC. : REVENUE, BY GEOGRAPHICAL SEGMENT, 2011 - 2013 (USD MN) 82
LIST OF FIGURES

FIGURE 1 GLOBAL NEUROSTIMULATION MARKET: SEGMENTATION and COVERAGE 11
FIGURE 2 INTERNAL NEUROSTIMULATION MARKET: INTEGRATED ECOSYSTEM 13
FIGURE 3 RESEARCH METHODOLOGY 14
FIGURE 4 TOP-DOWN APPROACH 15
FIGURE 5 BOTTOM-UP APPROACH 16
FIGURE 6 MACROINDICATOR BASED APPROACH 17
FIGURE 7 GLOBAL INTERNAL NEUROSTIMULATION MARKET SNAPSHOT 20
FIGURE 8 INTERNAL NEUROSTIMULATION MARKET: COMPARISON WITH PARENT MARKET 21
FIGURE 9 GLOBAL : INTERNAL NEUROSTIMULATION MARKET, BY GEOGRAPHY,
2013-2019 (USD MN) 22
FIGURE 10 GLOBAL: INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN) 26
FIGURE 11 GLOBAL: SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY,
2013-2019 (USD MN) 27
FIGURE 12 GLOBAL: DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN) 29
FIGURE 13 GLOBAL: SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY,
2013-2019 (USD MN) 31
FIGURE 14 GLOBAL: VAGUS NERVE STIMULATION MARKET, BY GEOGRAPHY,
2013-2019 (USD MN) 32
FIGURE 15 GLOBAL: GASTRIC ELECTRICAL STIMULATION MARKET, BY GEOGRAPHY,
2013-2019 (USD MN) 34
FIGURE 16 GLOBAL INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION,
2013-2019 (USD MN) 36
FIGURE 17 GLOBAL INTERNAL NEUROSTIMULATION IN PARKINSON'S DISEASE, BY GEOGRAPHY, 2013-2019 (USD MN) 38
FIGURE 18 GLOBAL INTERNAL NEUROSTIMULATION IN TREMOR, BY GEOGRAPHY,
2013-2019 (USD MN) 39
FIGURE 19 GLOBAL INTERNAL NEUROSTIMULATION IN DEPRESSION, BY GEOGRAPHY,
2013-2019 (USD MN) 40
FIGURE 20 GLOBAL INTERNAL NEUROSTIMULATION IN OTHER APPLICATIONS, BY GEOGRAPHY, 2013-2019 (USD MN) 41
FIGURE 21 NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET OVERVIEW,
2014 and 2019 (%) 44
FIGURE 22 NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION,
2013-2019 (USD MN) 45
FIGURE 23 NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET: APPLICATION SNAPSHOT 46
FIGURE 24 NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET, BY TYPE,
2013-2019 (USD MN) 46
FIGURE 25 NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET SHARE, BY TYPE,
2013-2019 (%) 47
FIGURE 26 EUROPE INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 and 2019 (%) 48
FIGURE 27 EUROPE INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION,
2013-2019 (USD MN) 48
FIGURE 28 EUROPE INTERNAL NEUROSTIMULATION MARKET: APPLICATION SNAPSHOT 49
FIGURE 29 EUROPE INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN) 50
FIGURE 30 EUROPE: INTERNAL NEUROSTIMULATION MARKET SHARE, BY TYPE, 2013-2019 (%) 51
FIGURE 31 ASIA INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 and 2019 (%) 51
FIGURE 32 ASIA INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION,
2013-2019 (USD MN) 52
FIGURE 33 ASIA INTERNAL NEUROSTIMULATION MARKET: APPLICATION SNAPSHOT 53
FIGURE 34 ASIA INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN) 53
FIGURE 35 ASIA INTERNAL NEUROSTIMULATION MARKET SHARE, BY TYPE, 2013-2019 (%) 54
FIGURE 36 ROW INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 and 2019 (%) 55
FIGURE 37 ROW INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION,
2013-2019 (USD MN) 56
FIGURE 38 ROW INTERNAL NEUROSTIMULATION MARKET: APPLICATION SNAPSHOT 57
FIGURE 39 ROW INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019(USD MN) 57
FIGURE 40 ROW: INTERNAL NEUROSTIMULATION MARKET SHARE, BY TYPE, 2013-2019 (%) 58
FIGURE 41 INTERNAL NEUROSTIMULATION: COMPANY PRODUCT COVERAGE, BY TYPE, 2013 60
FIGURE 42 BOSTON SCIENTIFIC CORPORATION REVENUE MIX, 2013 63
FIGURE 43 JOHNSON and JOHNSON, INC. REVENUE MIX, 2013 68
FIGURE 44 MEDTRONIC, PLC. REVENUE MIX, 2013 73
FIGURE 45 ST. JUDE MEDICAL. REVENUE MIX, 2013 76

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Parkinson%s Disease  - Market Insights, Epidemiology and Market Forecast-2023

Parkinson%s Disease  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Parkinson’s Disease - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and ...

EpiCast Report: Schizophrenia - Epidemiology Forecast to 2025

EpiCast Report: Schizophrenia - Epidemiology Forecast to 2025

  • $ 3995
  • Industry report
  • November 2016
  • by Global Data

EpiCast Report: Schizophrenia - Epidemiology Forecast to 2025 Summary Schizophrenia is a severe mental disorder that affects an individual’s behaviors, thoughts, and emotions; it is extremely heterogeneous, ...

Global Molecular Diagnostics 2010-2016: Deal trends, players, financials and forecasts

Global Molecular Diagnostics 2010-2016: Deal trends, players, financials and forecasts

  • $ 2995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Molecular Diagnostics Partnering 2010-2016 report provides a detailed understanding and analysis of how and why companies enter molecular diagnostics partnering deals. These deals tend to be ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.